German Homoeo Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Gaya, Bihar, India, established in 2022.
2022 Gaya, Bihar, India Active
Last Updated:
About German Homoeo Pharmaceuticals Private Limited

German Homoeo Pharmaceuticals Private Limited, a active private limited company, was established on 11 January 2022 in Gaya, Bihar, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290BR2022PTC055931. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Neha Kumari (Director), Ankit Kumar Karan (Managing Director). It is based at C/O- Ankit Kumar, Vill- Sobh, Panch-Rohi Tola- Sobh, Gaya, Bihar, 824201.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290BR2022PTC055931

  • Registration Number

    055931

  • Incorporation Date

    11 January 2022

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Patna

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 2 Months
Company report

German Homoeo Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into German Homoeo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at German Homoeo Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Neha Kumari Director 11 Jan 2022 Current
Ankit Kumar Karan Managing Director 11 Jan 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of German Homoeo Pharmaceuticals.

Enhance accessibility to German Homoeo Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

German Homoeo Pharmaceuticals revenue growth over time
German Homoeo Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of German Homoeo Pharmaceuticals?

Unlock access to German Homoeo Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at German Homoeo Pharmaceuticals?

German Homoeo Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of German Homoeo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped German Homoeo Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on German Homoeo Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Neha Kumari was appointed as a Director was appointed as a Director on 11 Jan 2022 & has been associated with this company since 4 years 2 months . was documented.

  • Director Appointment

    The activity Ankit Kumar Karan was appointed as a Managing Director was appointed as a Managing Director on 11 Jan 2022 & has been associated with this company since 4 years 2 months . was completed.

  • Company Incorporation

    The activity German Homoeo Pharmaceuticals Private Limited was registered on 11 Jan 2022 with Roc Patna & aged 4 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of German Homoeo Pharmaceuticals Private Limited?

The CIN of German Homoeo Pharmaceuticals Private Limited is U24290BR2022PTC055931.

Where is German Homoeo Pharmaceuticals Private Limited headquartered?

German Homoeo Pharmaceuticals Private Limited is headquartered at C/O- Ankit Kumar, Vill- Sobh, Panch-Rohi Tola- Sobh, Gaya, Bihar, 824201.

When was German Homoeo Pharmaceuticals Private Limited incorporated?

German Homoeo Pharmaceuticals Private Limited was incorporated on 11 January 2022.

Who are the current directors of German Homoeo Pharmaceuticals Private Limited?

The current directors of German Homoeo Pharmaceuticals Private Limited are

What is the primary industry of German Homoeo Pharmaceuticals Private Limited?

The primary industry of German Homoeo Pharmaceuticals Private Limited is Chemicals.

Is German Homoeo Pharmaceuticals Private Limited a listed company?

German Homoeo Pharmaceuticals Private Limited is unlisted.

What is the capital structure of German Homoeo Pharmaceuticals Private Limited?

The authorized capital of German Homoeo Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available